XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Collaborative Arrangements - AstraZeneca PLC - Narrative (Details) - Lynparza - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2022
Other Intangible Assets | Licenses and Other      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Finite-lived intangible assets $ 1,400    
AstraZeneca | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Probable contingent payments     $ 600
Liabilities     $ 600
Eligible future contingent sales-based milestone payments (up to) 2,100    
Regulatory milestone payments 245 $ 105  
Eligible future contingent regulatory milestone payments (up to) $ 650